Takeda
|
4,333.00 |
|
39.00 |
0.91% |
4.64% |
2025-04-30 |
Acadia Pharmaceuticals
|
14.58 |
|
0.15 |
1.04% |
-14.39% |
2025-04-30 |
Agios Pharmaceuticals
|
29.69 |
|
0.59 |
2.03% |
-11.79% |
2025-04-30 |
Alnylam Pharmaceuticals
|
263.23 |
|
6.04 |
2.35% |
75.62% |
2025-04-30 |
Amgen
|
290.99 |
|
2.07 |
0.72% |
4.11% |
2025-04-30 |
Arrowhead Research
|
13.89 |
|
0.42 |
3.12% |
-40.00% |
2025-04-30 |
Tectonic Therapeutic
|
20.86 |
|
0.64 |
3.14% |
42.43% |
2025-04-30 |
BioMarin Pharmaceutical
|
63.69 |
|
0.41 |
0.65% |
-23.55% |
2025-04-30 |
Incyte
|
62.66 |
|
2.23 |
3.69% |
18.38% |
2025-04-30 |
Ionis Pharmaceuticals
|
30.71 |
|
0.90 |
3.02% |
-28.60% |
2025-04-30 |
Moderna
|
28.56 |
|
0.75 |
2.70% |
-74.42% |
2025-04-30 |
Neurocrine Biosciences
|
107.69 |
|
0.45 |
0.42% |
-24.71% |
2025-04-30 |
Novartis
|
113.22 |
|
-0.22 |
-0.19% |
16.49% |
2025-04-30 |
PTC Therapeutics
|
49.82 |
|
0.30 |
0.61% |
45.84% |
2025-04-30 |
Ultragenyx Pharmaceutical
|
38.98 |
|
0.91 |
2.39% |
-9.91% |
2025-04-30 |
Regeneron Pharmaceuticals
|
598.42 |
|
29.50 |
5.19% |
-33.85% |
2025-04-30 |
Sanofi
|
54.96 |
|
1.25 |
2.33% |
9.91% |
2025-04-30 |
Sarepta Therapeutics
|
62.40 |
|
1.55 |
2.55% |
-52.28% |
2025-04-30 |
Vertex Pharmaceuticals
|
509.25 |
|
5.74 |
1.14% |
26.72% |
2025-04-30 |
Xencor
|
11.02 |
|
0.44 |
4.16% |
-53.95% |
2025-04-30 |